SEC Comment Letter 0000000000-25-003711 to InspireMD, Inc. (NSPR)
InspireMD, Inc.
Date: April 7, 2025 · CIK: 0001433607 · Accession: 0000000000-25-003711
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-286309
Letter
Re: InspireMD, Inc. Registration Statement on Form S-3 Filed April 1, 2025 File No. 333-286309 Dear Marvin Slosman:
April 7, 2025
Marvin Slosman President and Chief Executive Officer InspireMD, Inc. 6303 Waterford District Drive, Suite 215 Miami, FL 33126
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Nicholas O'Leary at 202-551-4451 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Industrial
Applications and
Services
cc: Raffael Fiumara, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> April 7, 2025 Marvin Slosman President and Chief Executive Officer InspireMD, Inc. 6303 Waterford District Drive, Suite 215 Miami, FL 33126 Re: InspireMD, Inc. Registration Statement on Form S-3 Filed April 1, 2025 File No. 333-286309 Dear Marvin Slosman: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Nicholas O'Leary at 202-551-4451 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Raffael Fiumara, Esq. </TEXT> </DOCUMENT>